ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brightling, C.
Right arrow Articles by Pavord, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brightling, C.
Right arrow Articles by Pavord, I.
Eur Respir J 2000; 15: 682-686
Copyright © ERS Journals Ltd 2000


Clinical Trial

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis

CE Brightling, R Ward, AJ Wardlaw, and ID Pavord

Eosinophilic bronchitis is a common cause of chronic cough, characterized by sputum eosinophilia similar to that seen in asthma, but unlike asthma the patients have no objective evidence of variable airflow obstruction or airway hyperresponsiveness. The reason for the different functional associations is unclear. The authors have tested the hypothesis that in eosinophilic bronchitis the inflammation is mainly localized in the upper airway. In an open study the authors measured the lower (provocative concentration causing a 20% fall in forced expiratory volume in one second (PC20)) and upper (PC25 MIF50) airway responsiveness to histamine, lower and upper airway inflammation using induced sputum and nasal lavage, in II patients with eosinophilic bronchitis. The authors assessed changes in these measures and in cough reflex sensitivity to capsaicin and cough severity after 400 microg of inhaled budesonide for 4 weeks. A nasal eosinophilia was present in only three patients with one having upper airway hyperresponsiveness. Following treatment with inhaled corticosteroids the geometric mean sputum eosinophil count decreased from 12.8% to 2.9% (mean difference 4.4-fold, 95% confidence interval (CI) 2.14-10.02), the mean +/- sem cough visual analogue score on a 100 mm scale decreased from 27.2 +/- 6.6 mm to 12.6 +/- 5.7 mm (mean difference 14.6, 95% CI 9.1-20.1) and the cough sensitivity assessed as the capsaicin concentration required to cause two coughs (C2) and five coughs (C5) improved (C2 mean difference 0.75 doubling concentrations, 95% CI 0.36-1.1; C5 mean difference 1.3 doubling concentration, 95% CI 0.6-2.1). There was a significant positive correlation between the fold change in sputum eosinophil count and doubling dose change in C5 after inhaled budesonide (r=0.61). It is concluded that upper airway inflammation is not prominent in eosinophilic bronchitis and that inhaled budesonide improves the sputum eosinophilia, cough severity and sensitivity suggesting a causal link between the inflammation and cough.


This article has been cited by other articles:


Home page
Chronic Respiratory DiseaseHome page
C. Barber and D Fishwick
Chronic cough - occupational considerations
Chronic Respiratory Disease, November 1, 2008; 5(4): 211 - 221.
[Abstract] [PDF]


Home page
Eur Respir JHome page
A. H. Morice, G. A. Fontana, M. G. Belvisi, S. S. Birring, K. F. Chung, P. V. Dicpinigaitis, J. A. Kastelik, L. P. McGarvey, J. A. Smith, M. Tatar, et al.
ERS guidelines on the assessment of cough
Eur. Respir. J., June 1, 2007; 29(6): 1256 - 1276.
[Full Text] [PDF]


Home page
ThoraxHome page
A H Morice, L McGarvey, I Pavord, and on behalf of the British Thoracic Society Cough Gu
Recommendations for the management of cough in adults
Thorax, September 1, 2006; 61(suppl_1): i1 - i24.
[Full Text] [PDF]


Home page
ChestHome page
B. J. Canning
Anatomy and Neurophysiology of the Cough Reflex: ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 33S - 47S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. E. Brightling
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis: ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 116S - 121S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. V. Dicpinigaitis and R. V. Alva
Safety of Capsaicin Cough Challenge Testing
Chest, July 1, 2005; 128(1): 196 - 202.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S S Birring, R B Patel, D Parker, S Mckenna, B Hargadon, W R Monteiro, J F Falconer Smith, and I D Pavord
Airway function and markers of airway inflammation in patients with treated hypothyroidism
Thorax, March 1, 2005; 60(3): 249 - 253.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
I. D. Pavord
Chronic cough: a rational approach to investigation and management
Eur. Respir. J., February 1, 2005; 25(2): 213 - 215.
[Full Text] [PDF]


Home page
ChestHome page
B. Prudon, S. S. Birring, D. D. Vara, A. P. Hall, J. P. Thompson, and I. D. Pavord
Cough and Glottic-Stop Reflex Sensitivity in Health and Disease
Chest, February 1, 2005; 127(2): 550 - 557.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S.-W. Park, Y. M. Lee, A. S. Jang, J. H. Lee, Y. Hwangbo, D. J. Kim, and C.-S. Park
Development of Chronic Airway Obstruction in Patients With Eosinophilic Bronchitis: A Prospective Follow-up Study
Chest, June 1, 2004; 125(6): 1998 - 2004.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Kanazawa, S. Nomura, and J. Yoshikawa
Role of Microvascular Permeability on Physiologic Differences in Asthma and Eosinophilic Bronchitis
Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1125 - 1130.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S.S. Birring, C. Passant, R.B. Patel, B. Prudon, G.E. Murty, and I.D. Pavord
Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough
Eur. Respir. J., February 1, 2004; 23(2): 199 - 201.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S S Birring, C E Brightling, F A Symon, S G Barlow, A J Wardlaw, and I D Pavord
Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis
Thorax, December 1, 2003; 58(12): 1066 - 1070.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A H Morice and J A Kastelik
Cough * 1: Chronic cough in adults
Thorax, October 1, 2003; 58(10): 901 - 907.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
C E Brightling, F A Symon, S S Birring, P Bradding, A J Wardlaw, and I D Pavord
Comparison of airway immunopathology of eosinophilic bronchitis and asthma
Thorax, June 1, 2003; 58(6): 528 - 532.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R.O. Crapo, R.L. Jensen, and F.E. Hargreave
Airway inflammation in COPD: physiological outcome measures and induced sputum
Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S S Birring, B Prudon, A J Carr, S J Singh, M D L Morgan, and I D Pavord
Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)
Thorax, April 1, 2003; 58(4): 339 - 343.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M Fujimura, H Ogawa, Y Nishizawa, and K Nishi
Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma?
Thorax, January 1, 2003; 58(1): 14 - 18.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
H Minoguchi, K Minoguchi, A Tanaka, H Matsuo, N Kihara, and M Adachi
Cough receptor sensitivity to capsaicin does not change after allergen bronchoprovocation in allergic asthma
Thorax, January 1, 2003; 58(1): 19 - 22.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Leader of the Working Group:, I.D. Pavord, Members of the Working Group:, P.J. Sterk, F.E. Hargreave, J.C. Kips, M.D. Inman, R. Louis, M.M.M. Pizzichini, E.H. Bel, et al.
Clinical applications of assessment of airway inflammation using induced sputum
Eur. Respir. J., July 1, 2002; 20(37_suppl): 40S - 43s.
[Full Text] [PDF]


Home page
ThoraxHome page
P G Gibson, M Fujimura, and A Niimi
Eosinophilic bronchitis: clinical manifestations and implications for treatment
Thorax, February 1, 2002; 57(2): 178 - 182.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Katayama, M. Fujimura, A. Ueda, T. Kita, M. Abo, H. Tachibana, S. Myou, and K. Kurashima
Effects of Carbocysteine on Antigen-Induced Increases in Cough Sensitivity and Bronchial Responsiveness in Guinea Pigs
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 975 - 980.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. E. BRIGHTLING, R. WARD, G. WOLTMANN, P. BRADDING, J. R. SHELLER, R. DWORSKI, and I. D. PAVORD
Induced Sputum Inflammatory Mediator Concentrations in Eosinophilic Bronchitis and Asthma
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 878 - 882.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the European Respiratory Society.